
Cervical AI
AI-assisted cervical screening support, image-quality assessment and patient navigation concepts, with a focus on settings where access to screening and specialist resources may be constrained.
Explore the healthcare portfolio ↗JazyNova Technologies develops AI-powered software and intelligent systems for healthcare, security, commerce and business operations — with cancer-related innovation as our leading priority.
JazyNova Technologies is a founder-led technology project bringing together artificial intelligence, computer vision, data analysis, digital workflows and connected hardware.
Our ambition is to transform practical ideas into clearly scoped, testable products that respond to real needs. We develop across several sectors, while placing healthcare innovation and cancer-related applications at the centre of our impact agenda.
AI, medical imaging and human expertiseWe are exploring digital tools that can support screening pathways, image review and continuity of care. The goal is to assist healthcare professionals and patient-centred services — not replace clinical judgement.

AI-assisted cervical screening support, image-quality assessment and patient navigation concepts, with a focus on settings where access to screening and specialist resources may be constrained.
Explore the healthcare portfolio ↗A breast-health AI initiative exploring image-based analysis support and clinical decision-support workflows.
A patient-centred concept for early-detection support, decision support and continuity across the lymphoma care pathway.
Technology should strengthen access, understanding and care coordination while keeping people and qualified professionals at the centre.
Healthcare is our priority. Beyond cancer-related innovation, our portfolio explores visual intelligence, connected retail, digital services and operational automation.

AI-assisted cervical screening support and patient navigation.
Prototype / technical refinement
Breast-health image analysis support concept and clinical workflow exploration.
Concept / development initiative
Patient-centred early-detection support and care-pathway continuity concept.
Development initiative
Camera-based monitoring concepts, event analysis and visual validation for defined operational environments.
Architecture / prototype concepts
Connected retail-cart and guided digital-service concepts to support product identification and service access.
Concept / prototype exploration
Digital process review, operational insights, workflow automation and performance-support tools.
Tools / concepts in developmentOur wider technology work applies AI, data and automation to improve how organisations monitor, serve customers and manage operations.

Video review, visual validation and event-flagging concepts. Human review, privacy safeguards and lawful use remain essential.

Connected carts, touchscreens, kiosks and guided workflows for retail and service environments.

Enterprise dashboards, process automation, customer operations and prospect-management support.
JazyNova’s health-technology research pathway spans cervical, breast, paediatric blood and pancreatic cancers, as well as multimodal oncology research. The records below identify the scientific events and the exact acceptance status documented for each contribution.
Singapore · 4–6 December 2026
Philadelphia, United States · 22–25 September 2026
Hong Kong · September 2026
Montreal, Canada · 3 October 2026
San Diego, United States · 25–28 September 2026
Hallmarks of Cancer · Sitges, Spain · 1–3 November 2026
Individual products can share reusable technical components while keeping separate workflows, permissions and deployment requirements.
Model development and inference for clearly defined use cases.
Image and video analysis, including object and event recognition.
Databases, analytics and API-based system connections.
Web and mobile interfaces, dashboards and operational workflows.
Cameras, kiosks, smart carts and edge devices where applicable.
Privacy, cybersecurity, interoperability and human oversight as design priorities.
A disciplined development path: focus, test, learn and scale only when the evidence supports it.
Prioritise the product, users, requirements and ownership of intellectual property.
Document functionality, run technical tests and improve reliability.
Conduct user discovery and seek appropriate research, clinical and industry collaboration.
Run limited pilots with safeguards, measure outcomes and refine the model before expansion.
JazyNova Technologies is led by two co-founders bringing together technology entrepreneurship, healthcare experience and a commitment to practical innovation.

Ibrahima Madougou Moubarak is an entrepreneur and public-interest leader working at the intersection of technology, AI innovation and healthcare advocacy. He leads JazyNova’s strategic direction, product vision, organisational development and partnership engagement.
He is the founder and President of the Ligue Nigérienne de Lutte contre le Cancer (LNLC-Niger), with experience in cancer prevention, awareness, advocacy and patient support. His international engagement includes work with cancer-control and patient-advocacy networks.
His academic background includes a Master 2 Research in Public Law. His work at JazyNova connects technology development with institutional strategy and real-world needs.

Illa Godi Bitrus is a medical doctor and healthcare innovation professional whose work combines clinical medicine, public health programmes, epidemiological monitoring and digital health initiatives.
His professional experience includes medical work with MSF Switzerland on a malaria programme in Gouré, Niger, where he contributed to clinical care, epidemiological monitoring and medical data reporting. His background also includes community health activities, medical coordination and data operations.
At JazyNova, his profile supports the healthcare innovation perspective, helping connect product development with clinical workflows, public-health needs and responsible digital-health use cases.
JazyNova is exploring Estonia as a potential base for company establishment, technology development, partnerships and access to the wider European market.
We see this next phase as an opportunity to structure the venture, strengthen technical validation, engage with specialist talent and develop products in a responsible, internationally connected environment.

JazyNova is currently founder-led. As products progress, the project intends to engage specialist contributors and build the capabilities needed for responsible delivery.
Ibrahima Madougou Moubarak
Founder & CEO — strategic direction, product vision, organisational development and partnership engagement.
AI engineering · Computer vision · Healthcare technology · Clinical and regulatory expertise · Data science · Enterprise intelligence · Hardware and IoT integration.
We believe a strong technology venture should communicate clearly about what exists today and what still needs to be built.
JazyNova is presented here as a technology project under development and is exploring Estonia as a potential base. This website does not claim that an Estonian company has already been incorporated.
No clinical approval or regulatory certification is claimed. Clinical evaluation, regulatory assessment, data protection and qualified healthcare-professional oversight are necessary before clinical deployment.
No. Cancer-related healthcare innovation is our leading priority, alongside intelligent security, smart commerce, business intelligence, AI marketing and smart mobility concepts.
The project is currently founder-led. Specialist capabilities are identified as future recruitment and collaboration priorities as the venture develops.
Institutions, research groups, technology specialists and potential pilot users can contact the founder to discuss relevant opportunities.
We welcome discussions with research, healthcare, technology and industry stakeholders.